...
首页> 外文期刊>Die Pharmazie >Correlation and in vitro studies on radioactive and nonradioactive albendazole-beta-cyclodextrin complex tablets.
【24h】

Correlation and in vitro studies on radioactive and nonradioactive albendazole-beta-cyclodextrin complex tablets.

机译:放射性和非放射性阿苯达唑-β-环糊精复合物片剂的相关性和体外研究。

获取原文
获取原文并翻译 | 示例
           

摘要

The work aims to confirm the complexation of albendazole (ABZ) by beta-cyclodextrin (beta-CD), and to compare them with pure ABZ tablets using radioactive and nonradioactive dissolution studies. The complex tablets were prepared by kneading a binary mixture of ABZ and beta-CD and a direct compression method. Nuclear magnetic resonance (NMR) spectroscopy, scanning electron microscopy (SEM) and Fourier transform infrared (FTIR) spectroscopy were examined to prove the formation of complexes in the final products. The radiolabelled tablets were labelled with 99mTc-DTPA. Dissolution studies were performed with radiolabelled and nonradiolabelled tablets in two dissolution media (pH 1.2 and pH 7.4). The tablets were added to an acidic solution (pH = 1.2) to quantify the concentration of the drug inside the beta-CD cavity. The other medium (pH = 7.4) was used to prove the existence of non-complexed drug in each powder, as the drug's solubility increases with pH. It was observed that complexation occurred in all tablets, and beta-cyclodextrin (beta-CD) could increase the aqueous solubility. Further, a correlation was shown between dissolution results for radiolabelled and nonradiolabelled tablets. This study shows that the characterization studies were a good indicator for the ABZ: beta-CD complex. According to the phase solubility studies, the solubility of ABZ increased when the amount of beta-CD increased, and drug release from tablets in pH 7.4 and pH 1.2 media was dramatically improved by the addition of beta-CD compared with the pure ABZ tablet.
机译:这项工作旨在确认阿苯达唑(ABZ)与β-环糊精(β-CD)的络合作用,并通过放射性和非放射性溶出度研究将它们与纯ABZ片剂进行比较。通过将ABZ和β-CD的二元混合物捏合并直接压制方法来制备复合片剂。检查了核磁共振(NMR)光谱,扫描电子显微镜(SEM)和傅立叶变换红外(FTIR)光谱,以证明最终产物中形成了配合物。放射性标记的片剂用99mTc-DTPA标记。用放射性标记的和非放射性标记的片剂在两种溶出介质(pH 1.2和pH 7.4)中进行溶出研究。将片剂加至酸性溶液(pH = 1.2)中,以定量β-CD腔内药物的浓度。使用另一种介质(pH = 7.4)来证明每种粉末中都存在非复合药物,因为药物的溶解度随pH的增加而增加。观察到在所有片剂中均发生络合,并且β-环糊精(β-CD)可以增加水溶性。此外,显示了放射性标记和非放射性标记的片剂的溶出结果之间的相关性。这项研究表明,表征研究是ABZ:β-CD复合物的良好指标。根据相溶解度研究,当β-CD量增加时,ABZ的溶解度增加,与纯ABZ片剂相比,通过添加β-CD可以显着改善pH 7.4和pH 1.2介质中片剂的药物释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号